Shattuck Labs Inc — Balance Sheet (NASDAQ:STTK) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 348.99 M298.58 M205.32 M159.56 M91.05 M Total liabilities 39.13 M26.8 M29.17 M14.86 M11.42 M Total equity 309.86 M271.79 M176.16 M144.71 M79.63 M Total liabilities & shareholders' equities 348.99 M298.58 M205.32 M159.56 M91.05 M Total debt ————— Net debt —————

ニュース

パイパー・サンドラー、シャタック・ラボの株式を「オーバーウェイト」で新規カバー開始

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

H.C. ワインライト、シャタック・ラボの評価を「買い」に引き上げ

Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright

Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript

シャタック・ラボ、UEG会議で革新的IBD治療の知見を発表

Shattuck Labs at UEG Congress: Innovative IBD Treatment Insights

What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?

Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?